Canna~Fangled Abstracts Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders. Lancet Neurol. 2019 Mar 22. pii: S1474-4422(19)30032-8. doi: 10.1016/S1474-4422(19)30032-8. Friedman D1, French JA2, Maccarrone M3.…Freedom WaresMarch 22, 2019
Canna~Fangled Abstracts How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review. Eur Arch Psychiatry Clin Neurosci. 2019 Jan 31. doi: 10.1007/s00406-019-00984-4. Hoch E1, Niemann D2, von…Freedom WaresJanuary 31, 2019
Canna~Fangled Abstracts Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. Eur Neuropsychopharmacol. 2017 May 30. pii: S0924-977X(17)30237-7. doi: 10.1016/j.euroneuro.2017.05.005. Cooper RE1, Williams E2, Seegobin S3,…Freedom WaresMay 30, 2017
For Your Consideration... Prescription Stimulants – The Most Real And Serious Contributor To Psychosis. December 2015Volume 71, Pages 41–47 McLean Hospital, Psychotic Disorders Division, Belmont, MA, Harvard Medical School,…Freedom WaresNovember 4, 2015
For Your Consideration... Prescription stimulant use is associated with earlier onset of psychosis. Journal List > HHS Author Manuscripts > PMC4630672 J Psychiatr Res. Author manuscript; available in PMC 2016 Dec 1.…Freedom WaresNovember 3, 2015
Canna~Fangled Abstracts Medical Marijuana: Review of the Science and Implications for Developmental-Behavioral Pediatric Practice. 2015 February/March;36(2):115-123. Hadland SE1, Knight JR, Harris SK. Author information Abstract Marijuana policy is rapidly evolving in…Freedom WaresFebruary 5, 2015